Digital Health Enablement

Medioh offers full-circle logistics, asset management, and patient engagement support for organizations engaging in new models of care. 

We partner with leading providers to scale solutions in our ultimate mission to build more sustainable healthcare systems. 

• Medioh manages the entire lifecycle of digital health / remote patient monitoring (RPM) technologies, devices, and assets, as well as patient experience with them. 

• We support patients every step of the way in their remote care journey, so that tech issues and onboarding don't get in the way of patients getting on board with their programs. 

• Medioh's solutions are vendor and device agnostic, allowing providers to focus on care, instead of technology and logistics.

• From procurement and system integration to shipping, asset management and patient support, we ensure safety, quality, and patient / member experience are never sacrificed for volume.

Medioh’s solutions are fully compliant with all FDA, ISO, HIPAA, and Canada Health requirements for data security and patient health information privacy.

The Logistics & Patient Engagement Partner for North America's Largest RPM & Digital Health Programs.

Biofourmis Care is a holistic, customizable, end-to-end solution that delivers virtual care to patients with acute, post-acute, and chronic medical conditions in the comfort of their own homes. Medical-grade wearables allow for continuous, real-time monitoring and patient-specific notifications enable caregivers to deliver exceptional care to patients anywhere. Our 24/7 virtual clinical care team, staffed by health navigators, nurses, and physicians can monitor and manage patients with acute or chronic medical conditions. Biofourmis Care is powered by the FDA-cleared Biovitals Analytics Engine and Biovitals Index which utilizes artificial intelligence and machine learning to interpret and analyze physiological signals, delivering personalized patient insight. Additional Biofourmis Care features and services include:

Biofourmis brings the right care to every person, no matter where they are. The company’s AI-driven solutions provide people everywhere with connected access to hospital-level services, virtual provider networks for remote care, and life-changing clinical trials—all without leaving their homes. Trusted by leading health systems, life science companies and patients alike, Biofourmis’ connected platform improves patient outcomes, accelerates drug development, and closes critical gaps in care—ultimately making science smarter, healthcare simpler, and patients healthier.

Differentiators from Internal Solutions:

• Economies of scale on shipping and logistics
• Established quality systems based on ISO 13485, FDA regulatory compliance, proven processes.
• Inventory / Warehousing / Fulfilment capacity and strategic regional facilities
• Improved operational efficiency
• Enhanced patient engagement and experience
• Proven cost savings relative to in-house options

Differentiators:

• Economies of scale on shipping and logistics
• North American coverage to maximize efficiency and minimize shipping costs (our fulfilment facilities provide coast to coast coverage)
• Mature ISO 13845-based quality systems and full regulatory compliance.
• Medioh is a certified FDA repackager / relabeler.

Biofourmis Care is a remote patient management solution that can be deployed and scaled across health systems as an enabler or as a provider of care. 

One platform - The Biofourmis platform can support patients across the care continuum, from acute and post-acute conditions to complex chronic diseases.

End-to-End Solution - From patient onboarding, training, delivery logistics, clinical monitoring, billing, and technical support, Biofourmis Care offers every component needed to delivers remote patient care.

FDA-Cleared Analytics Engine - Machine learning model that creates a personalized baseline for individual patients based on continuous physiological signals and uses multiparametric data to derive clinical insights. Shown to significantly reduce false positive notifications in both acute and post-acute care settings.